Cargando…
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both...
Autores principales: | Higgins, Peter D R, Ng, Siew, Danese, Silvio, Rao, Krishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184434/ https://www.ncbi.nlm.nih.gov/pubmed/32377636 http://dx.doi.org/10.1093/crocol/otaa026 |
Ejemplares similares
-
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020) -
Aktueller Stand der Impfung gegen SARS-CoV-2
por: Iking-Konert, Christof, et al.
Publicado: (2021) -
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management
por: Crisci, Carlos D., et al.
Publicado: (2020) -
Safety of breast/chest-feeding by those infected by SARS-CoV-2
por: Powell, Rebecca L.R.
Publicado: (2022) -
Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019
por: Cheong, Kai Xiong
Publicado: (2020)